18F-FETNIM PET/CT测定的缺氧与胶质瘤患者总生存期的相关性
结果显示SUVmax与胶质瘤分级及上述标志物表达均显著相关,高SUVmax患者3年OS显著差于低SUVmax患者。
要点
- 18F-FETNIM PET/CT的SUVmax与胶质瘤分级显著相关(r=0.881,P<0.001)。
- SUVmax与HIF-1α、Ki-67、VEGF、MMP-9表达均显著相关(均P<0.001)。
- 高SUVmax患者3年OS显著低于低SUVmax患者(24.4% vs. 82.1%,P=0.003)。
核心结论
- 18F-FETNIM PET/CT可无创评估胶质瘤缺氧,并有助于理解缺氧影响胶质瘤患者OS的机制。
研究设计与样本
- 从肿瘤组织PET图像获取SUVmax,并对立体定向获取的肿瘤标本行HIF-1α、Ki-67、VEGF和MMP-9免疫组化染色。
主要发现
- SUVmax与胶质瘤分级相关(r=0.881,P<0.001)。
- SUVmax与HIF-1α、Ki-67、VEGF、MMP-9表达显著相关(r=0.820、0.747、0.606、0.727;均P<0.001)。
- 高SUVmax患者3年OS显著差于低SUVmax患者(24.4% vs. 82.1%,P=0.003)。
临床怎么用
- 对拟行手术的胶质瘤患者,可考虑术前18F-FETNIM PET/CT测定SUVmax以无创评估肿瘤缺氧程度。
- SUVmax较高提示肿瘤分级更高、缺氧/增殖/血管生成/侵袭相关标志物表达更强且3年OS更差,可辅助风险分层。
局限性
- 研究对象为可安全尝试大体全切除的胶质瘤患者,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hypoxia is important in the biology of glioma in humans. Positron emission tomography/computed tomography (PET/CT) with a hypoxia tracer offers a noninvasive method to differentiate individual tumor biology and potentially modify treatment for patients with malignancies. The purpose of this study was to determine whether hypoxia, as measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET/CT, was associated with tumor grade, overall survival (OS), and immunohistochemical features related to hypoxia, proliferation, angiogenesis, and the invasion of gliomas. PROCEDURES: Twenty-five patients with gliomas in whom gross maximal resection could be safely attempted were analyzed. All patients underwent 18F-FETNIM PET/CT studies before surgery. The maximum standardized uptake value (SUVmax) was obtained from the PET images of tumor tissues. Tumor specimens were stereotactically obtained for the immunohistochemical staining of hypoxia-inducible factor-1 alpha (HIF-1α), Ki-67, vascular endothelial growth factor (VEGF), and matrix metalloproteinase 9 (MMP-9). RESULTS: A correlation between the SUVmax and glioma grade was found (r = 0.881, P < 0.001). The SUVmax was significantly correlated with the expression of HIF-1α, Ki-67, VEGF, and MMP-9 (r = 0.820, 0.747, 0.606, and 0.727; all P < 0.001). Patients with a high SUVmax had significantly worse 3-year OS than those with a low SUVmax (24.4% vs. 82.1%, P = 0.003). CONCLUSIONS: 18F-FETNIM PET/CT provides an excellent noninvasive assessment of hypoxia in glioma. It can be used to understand the mechanisms by which hypoxia affects the OS of glioma patients.
引用
- Hu M, Zhu Y, Mu D, et al. Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET/CT and overall survival in glioma patients. Eur J Nucl Med Mol Imaging. 2019. PMID: 31776634. doi:10.1007/s00259-019-04621-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。